chr1-11934761-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000302.4(PLOD1):​c.-19C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000583 in 1,373,358 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000058 ( 1 hom. )

Consequence

PLOD1
NM_000302.4 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0440

Publications

0 publications found
Variant links:
Genes affected
PLOD1 (HGNC:9081): (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) Lysyl hydroxylase is a membrane-bound homodimeric protein localized to the cisternae of the endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VI have deficiencies in lysyl hydroxylase activity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PLOD1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, kyphoscoliotic type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLOD1NM_000302.4 linkc.-19C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 19 ENST00000196061.5 NP_000293.2 Q02809-1
PLOD1NM_000302.4 linkc.-19C>T 5_prime_UTR_variant Exon 1 of 19 ENST00000196061.5 NP_000293.2 Q02809-1
PLOD1NM_001316320.2 linkc.-19C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 20 NP_001303249.1 Q02809-2
PLOD1NM_001316320.2 linkc.-19C>T 5_prime_UTR_variant Exon 1 of 20 NP_001303249.1 Q02809-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLOD1ENST00000196061.5 linkc.-19C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 19 1 NM_000302.4 ENSP00000196061.4 Q02809-1
PLOD1ENST00000196061.5 linkc.-19C>T 5_prime_UTR_variant Exon 1 of 19 1 NM_000302.4 ENSP00000196061.4 Q02809-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000167
AC:
2
AN:
120010
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000283
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000119
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000583
AC:
8
AN:
1373358
Hom.:
1
Cov.:
31
AF XY:
0.00000295
AC XY:
2
AN XY:
677600
show subpopulations
African (AFR)
AF:
0.0000347
AC:
1
AN:
28850
American (AMR)
AF:
0.00
AC:
0
AN:
34750
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24622
East Asian (EAS)
AF:
0.0000594
AC:
2
AN:
33684
South Asian (SAS)
AF:
0.0000516
AC:
4
AN:
77448
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4538
European-Non Finnish (NFE)
AF:
9.31e-7
AC:
1
AN:
1073978
Other (OTH)
AF:
0.00
AC:
0
AN:
57232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 21, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
11
DANN
Benign
0.91
PhyloP100
0.044
PromoterAI
-0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs931657528; hg19: chr1-11994818; API